Project Grant K23DA063970
Award Date 5/1/26
Completion Date 4/30/31
Dollars Obligated $195K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a $159,615 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 15, 2025, for research extending through June 30, 2027. This K99/R00 award supports a research initiative titled "Predicting Craving and Relapse Using Neurobehavioral Markers of Goals and Habits in Opioid Use Disorder." The project delivers longitudinal neurobehavioral...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $169,776 to the University of California, Los Angeles on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). This five-year research initiative, directed by Dr. Annette Dekker and extending through April 30, 2031, delivers a comprehensive health services research study examining the impact of California's Bridge Initiative policy on emergency department (ED)-initiated...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $787,594 under the Drug Use and Addiction Research Programs (CFDA 93.279) for research on the cortical mechanisms of opioid reinforcement. The award, effective September 1, 2025, through May 31, 2030, supports a comprehensive research program investigating the molecular, cellular, and circuit-based mechanisms underlying opioid use disorder...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a $1,517,762 Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) effective July 1, 2025, through March 31, 2030. The award supports research leveraging integrative computational modeling and artificial intelligence-based tools to develop safer opioid therapeutics. The research addresses the critical public health challenge of opioid misuse and overdose...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $195,428 to Icahn School of Medicine at Mount Sinai under the Drug Use and Addiction Research Programs (CFDA 93.279) on February 15, 2026, for a K23 Career Development Award extending through January 31, 2031. Under this award, Principal Investigator Dr. Jennifer Love will develop and operate a clinical registry for Emergency Department (ED) patients with opioid use disorder exposed to xylazine and novel...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a K23 Career Development Award totaling $388,222 to Icahn School of Medicine at Mount Sinai, effective August 1, 2025, through July 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). Dr. Renny will develop and pilot test the Pediatric Emergency Department-Initiated Support Program to Link Care (PEDS-TLC), an emergency department-based intervention designed to link youth with substance use...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a $2,350,996 Project Grant on February 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research examining the intersection of Human Immunodeficiency Virus (HIV) infection and opioid use disorder in the nucleus accumbens brain region. The award supports a four-year research initiative (through January 31, 2030) focused on mining...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a $193,751 Career Development Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) to the Trustees of Boston University, effective May 1, 2026 through April 30, 2031, to support research advancing the quality of care for Medicaid enrollees in outpatient substance use disorder (SUD) treatment facilities. The award funds the development of an independent researcher in SUD services through a rigorous...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,640 Project Grant to Massachusetts General Hospital (MGH), effective March 1, 2026 through February 28, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This four-year research initiative will deliver clinical outcomes research and health economic analysis focused on integrating infectious disease (ID) care into rapid-access substance use disorder (SUD) bridge clinics. The project...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Mentored Career Development Grant of $169,167 to Indiana University Indianapolis, effective May 1, 2026 through April 30, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This project aims to improve access to and quality of adolescent opioid use disorder (OUD) and substance use disorder (SUD) services within primary care settings. The research responds to escalating adolescent...